These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 12189309

  • 1. Atrial natriuretic peptides in the diagnosis and treatment of congestive heart failure.
    Vesely DL.
    Congest Heart Fail; 1999; 5(4):171-179. PubMed ID: 12189309
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
    Vesely DL, Perez-Lamboy GI, Schocken DD.
    Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
    [Abstract] [Full Text] [Related]

  • 4. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.
    Vesely DL, Perez-Lamboy GI, Schocken DD.
    J Card Fail; 2001 Mar; 7(1):55-63. PubMed ID: 11264551
    [Abstract] [Full Text] [Related]

  • 5. Natriuretic peptides and acute renal failure.
    Vesely DL.
    Am J Physiol Renal Physiol; 2003 Aug; 285(2):F167-77. PubMed ID: 12842858
    [Abstract] [Full Text] [Related]

  • 6. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A.
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [Abstract] [Full Text] [Related]

  • 7. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression.
    Vesely DL.
    IUBMB Life; 2002 Mar; 53(3):153-9. PubMed ID: 12102171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research.
    Bełtowski J, Wójcicka G.
    Med Sci Monit; 2002 Feb; 8(2):RA39-52. PubMed ID: 11859295
    [Abstract] [Full Text] [Related]

  • 10. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.
    Vesely DL, Dietz JR, Parks JR, Baig M, McCormick MT, Cintron G, Schocken DD.
    Circulation; 1998 Jul 28; 98(4):323-9. PubMed ID: 9711937
    [Abstract] [Full Text] [Related]

  • 11. Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.
    Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR, Vesely DL.
    Eur J Clin Invest; 2006 Nov 28; 36(11):810-9. PubMed ID: 17032349
    [Abstract] [Full Text] [Related]

  • 12. Urodilatin: a better natriuretic peptide?
    Vesely DL.
    Curr Heart Fail Rep; 2007 Sep 28; 4(3):147-52. PubMed ID: 17883990
    [Abstract] [Full Text] [Related]

  • 13. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 28; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL, Geeranavar S, Jennings SC, Loke I, O'Brien RJ.
    Clin Sci (Lond); 2004 Feb 28; 106(2):129-33. PubMed ID: 13678415
    [Abstract] [Full Text] [Related]

  • 15. Combined treatment with vessel dilator and kaliuretic hormone in persons with congestive heart failure.
    Patel H, Dietz JR, Owen A, San Miguel G, McCormick MT, Schocken DD, Vesely DL.
    Exp Biol Med (Maywood); 2004 Jun 28; 229(6):521-7. PubMed ID: 15169971
    [Abstract] [Full Text] [Related]

  • 16. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
    Nakamura T, Funayama H, Yoshimura A, Tsuruya Y, Saito M, Kawakami M, Ishikawa SE.
    Int J Cardiol; 2006 Jan 13; 106(2):191-5. PubMed ID: 16321691
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S, Adamopoulos S, Parissis JT, Rassias J, Kostakis G, Iliodromitis E, Degiannis D, Kremastinos DT.
    Int J Cardiol; 2005 Mar 30; 99(3):409-13. PubMed ID: 15771921
    [Abstract] [Full Text] [Related]

  • 18. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone.
    Vesely DL.
    Clin Exp Pharmacol Physiol; 1995 Feb 30; 22(2):108-14. PubMed ID: 7621602
    [Abstract] [Full Text] [Related]

  • 19. Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
    Eichelbaum EJ, Sun Y, Alli AA, Gower WR, Vesely DL.
    Eur J Clin Invest; 2008 Aug 30; 38(8):562-70. PubMed ID: 18717826
    [Abstract] [Full Text] [Related]

  • 20. Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure.
    Vesely DL, Dietz JR, Parks JR, Antwi EA, Overton RM, McCormick MT, Cintron G, Schocken DD.
    Am Heart J; 1999 Oct 30; 138(4 Pt 1):625-32. PubMed ID: 10502206
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.